Abstract
A wide range of evidence shows that acetylcholinesterase (AChE) inhibitors can
Keywords: donepezil hydrochloride, acetylcholinesterase inhibitors, alzheimer s disease, AChE inhibitors, cortical cholinergic neurotransmission, hepatotxic liability, physostigmine, cholineric enhancement therapy, ACh releasers, M1 M3 Receptor agonists, nicotinic agonists, velnacrine, amiridine, eptastigmine, galanthamine, rivastigmine, metrifonate, huperzine A, donepezil hydrocloride, anti AChE Activity, n alkyl analogs, molecular modeling, receptor dependent docking, crystal structure, BuChE, Brain acetylcholine concentrations, TAK 147, anti inflammatory agents, alzheimer s disease treatment, estrogen replacement therapy, anti oxidants, anti amyloid, galanin receptor antagonist
Current Medicinal Chemistry
Title: Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors
Volume: 7 Issue: 3
Author(s): Hachiro Sugimoto, Yoshiharu Yamanish, Youichi Iimura and Yoshiyuki Kawakami
Affiliation:
Keywords: donepezil hydrochloride, acetylcholinesterase inhibitors, alzheimer s disease, AChE inhibitors, cortical cholinergic neurotransmission, hepatotxic liability, physostigmine, cholineric enhancement therapy, ACh releasers, M1 M3 Receptor agonists, nicotinic agonists, velnacrine, amiridine, eptastigmine, galanthamine, rivastigmine, metrifonate, huperzine A, donepezil hydrocloride, anti AChE Activity, n alkyl analogs, molecular modeling, receptor dependent docking, crystal structure, BuChE, Brain acetylcholine concentrations, TAK 147, anti inflammatory agents, alzheimer s disease treatment, estrogen replacement therapy, anti oxidants, anti amyloid, galanin receptor antagonist
Abstract: A wide range of evidence shows that acetylcholinesterase (AChE) inhibitors can
Export Options
About this article
Cite this article as:
Sugimoto Hachiro, Yamanish Yoshiharu, Iimura Youichi and Kawakami Yoshiyuki, Donepezil Hydrochloride (E2020) and Other Acetylcholinesterase Inhibitors, Current Medicinal Chemistry 2000; 7 (3) . https://dx.doi.org/10.2174/0929867003375191
DOI https://dx.doi.org/10.2174/0929867003375191 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteomics for Transthyretin (TTR) Related Amyloidosis
Current Proteomics Hypertension and Compliance to Treatment in the Primary Care Setting: Key Issues from the Literature Review
Current Hypertension Reviews Central Nervous System Agents for Ischemic Stroke: Neuroprotection Mechanisms
Central Nervous System Agents in Medicinal Chemistry Maintenance CBT in Preventing Relapse in Patients on SSRI Continuation
Current Psychopharmacology Mitochondrial Metabolism Modulation: A New Therapeutic Approach for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Toxin-Labeled Monoclonal Antibodies
Current Pharmaceutical Biotechnology A Method for Precise Extraction of EEG Rhythmic Activities Using Multivariate Empirical Mode Decomposition and the Hilbert Transform
Neuroscience and Biomedical Engineering (Discontinued) Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?
CNS & Neurological Disorders - Drug Targets Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine The Underlying Role of Oxidative Stress in Neurodegeneration: A Mechanistic Review
CNS & Neurological Disorders - Drug Targets Inhibition of Ataxia Telangiectasia-p53-E2F-1 Pathway in Neurons as a Target for the Prevention of Neuronal Apoptosis
Current Drug Metabolism Moving Beyond Tyrosine Hydroxylase to Define Dopaminergic Neurons for Use in Cell Replacement Therapies for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Partnerships Between Philanthropy, Government and Investors are Needed to Advance Drug Discovery for Neurodegenerative Diseases
Current Alzheimer Research Mutational Analysis of the Serotonergic System: Recent Findings Using Knockout Mice
Current Drug Targets - CNS & Neurological Disorders Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) Therapeutic Potential of Co-enzyme Q10 in Retinal Diseases
Current Medicinal Chemistry Sulfonyl Group-Containing Compounds in the Design of Potential Drugs for the Treatment of Diabetes and Its Complications
Current Medicinal Chemistry Influence of Aging on the Dopaminergic Neurons in the Substantia Nigra Pars Compacta of Rats
Current Aging Science